Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
The Annals of Pharmacotherapy|April 14, 2005
Etoricoxib: a highly selective COX-2 inhibitorShaunta' D Martina, Kimi S Vesta, Toni L RipleyAmerican Journal of Pharmaceutical Education|April 24, 2010
Integration of team-based learning strategies into a cardiovascular moduleSusan E Conway, Jeremy L Johnson, Toni L RipleyClinical Interventions in Aging|December 1, 2007
Candesartan in heart failureToni L Ripley, Jennifer S Chonlahan, Robin E GermanyPharmacotherapy|November 13, 2004
Early evaluation of hematuria in a patient receiving anticoagulant therapy and detection of malignancyToni L Ripley, Dawn E Havrda, Steve Blevins, et al.Clinical Therapeutics|April 20, 2010
Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort studyToni L Ripley, Donald Harrison, Robin E Germany, et al.Pharmacy Practice|October 25, 2013
Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot studyToni L Ripley, Thomas A Hennebry, Tiffany N Sanders, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 11, 2018
Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related MortalityAshley N Fox, Grant H Skrepnek, Jamie L Miller, et al.Therapeutic Advances in Drug Safety|June 15, 2016
Propofol-associated QTc prolongationMichael J Scalese, Holly R Herring, R Chris Rathbun, et al.The Annals of Pharmacotherapy|December 11, 2013
Collaborative practice model between cardiologists and clinical pharmacists for management of patients with cardiovascular disease in an outpatient clinicToni L Ripley, Philip B Adamson, Thomas A Hennebry, et al.Pharmacotherapy|July 29, 2008
Key articles and guidelines in the management of hypertension: 2008 updateSarah M Gaffney, Simon de Denus, Kari L Olson, et al.Pageof 3